AkupunkturPraxis 2022; 3(02): 70-79
DOI: 10.1055/a-1758-8484
CME-Fortbildung

Erkrankungen der Mutter während der Schwangerschaft

Judith Kruse
,
Guillermo Pierdant

Erkrankungen der Mutter während der Schwangerschaft sind gesundheitliche Probleme, die zu erheblichen maternalen und neonatalen Komplikationen führen können. Die ärztliche Betreuung hat das Ziel, potenzielle Gesundheitsprobleme frühzeitig zu erkennen und geeignete Maßnahmen zu ihrer Bewältigung zu ergreifen. Im Blickpunkt stehen die Gesundheit der Mutter sowie die des Fetus. In diesem Beitrag werden wir uns mit einigen der häufigsten Erkrankungen der Mutter während der Schwangerschaft befassen.



Publication History

Article published online:
16 May 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • Literatur

  • 1 Koot MH, Boelig RC, Van’t Hooft J. et al. Variation in hyperemesis gravidarum definition and outcome reporting in randomised clinical trials: a systematic review. Bjog 2018; 125: 1514-1521
  • 2 Goodwin TM. Hyperemesis gravidarum. Obstet Gynecol Clin North Am 2008; 35: 401-417
  • 3 Frulloni L, Patrizi F, Bernardoni L, Cavallini G. Pancreatic hyperenzymemia: clinical significance and diagnostic approach. Jop 2005; 6: 536-551
  • 4 Hummel M. Diabetes und Schwangerschaft: Was alles zu beachten ist. Dtsch Arztebl 2014; 111: 12-13
  • 5 Kleinwechter HBC, Hunger-Battefeld W, Kainer F. et al. Diabetes und Schwangerschaft. Evidenzbasierte Leitlinie der Deutschen Diabetes-Gesellschaft. AWMF Online 2014
  • 6 Yang JCE, O’Connell C, Jangaard K. Fetal and neonatal outcomes of diabetic pregnancies. Obstet Gynecol 2006; 108: 644-650
  • 7 Intensivmedizin GfNuP, Deutsche Gesellschaft für Perinatale Medizin dDD-G, Hebammenwissenschaft DGf, Deutscher Hebammenverband, Jugendmedizin DGfK-u, Geburtshilfe DGfGu. Betreuung von Neugeborenen diabetischer Mütter. AWMF Online; 2017
  • 8 Kamalakannan D, Baskar V, Barton DM, Tam A. Diabetic ketoacidosis in pregnancy. Postgrad Med J 2003; 79: 454-457
  • 9 DDG D. S3-Leitlinie Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge. 2. Aufl. AWMF Online; 2018
  • 10 Hypertensive Pregnancy Disorders: Diagnostics and Therapy. Guidline of the German Society of Gynecology and Obstetrics (S2-Level, AWMF-Registry No 015/018, March 2019); 2019
  • 11 Kattah AGGV. The management of hypertension in pregnancy. Adv Chronic Kidney Dis 2013; 20: 229-239
  • 12 Rana SLE, Granger JP, Karumanchi SA. Preeclampsia: Pathophysiology, Challenges, and Perspectives. Circ Res 2019; 124: 1094-1112
  • 13 Zambrano LD, Ellington S, Strid P. et al. Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status – United States, January 22–October 3, 2020. MMWR Morb Mortal Wkly Rep 2020; 69: 1641-1647
  • 14 Allotey J, Stallings E, Bonet M. et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. Bmj 2020; 370: m3320
  • 15 Woodworth KR, Olsen EO, Neelam V. et al. Birth and Infant Outcomes Following Laboratory-Confirmed SARS-CoV-2 Infection in Pregnancy – SET-NET, 16 Jurisdictions, March 29–October 14, 2020. MMWR Morb Mortal Wkly Rep 2020; 69: 1635-1640
  • 16 Elshafeey F, Magdi R, Hindi N. et al. A systematic scoping review of COVID-19 during pregnancy and childbirth. Int J Gynaecol Obstet 2020; 150: 47-52
  • 17 Lowenstein CJ, Solomon SD. Severe COVID-19 Is a Microvascular Disease. Circulation 2020; 142: 1609-1611
  • 18 Cuker A, Tseng EK, Nieuwlaat R. et al. American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19. Blood Adv 2021; 5: 872-888
  • 19 Kirtsman M, Diambomba Y, Poutanen SM. et al. Probable congenital SARS-CoV-2 infection in a neonate born to a woman with active SARS-CoV-2 infection. Cmaj 2020; 192: E647-E650
  • 20 Vivanti AJ, Vauloup-Fellous C, Prevot S. et al. Transplacental transmission of SARS-CoV-2 infection. Nat Commun 2020; 11: 3572
  • 21 Von Kohorn I, Stein SR, Shikani BT. et al. In Utero Severe Acute Respiratory Syndrome Coronavirus 2 Infection. J Pediatric Infect Dis Soc 2020; 9: 769-771
  • 22 Goh XL, Low YF, Ng CH. et al. Incidence of SARS-CoV-2 vertical transmission: a meta-analysis. Arch Dis Child Fetal Neonatal Ed 2021; 106: 112-113
  • 23 Ciapponi A, Bardach A, Mazzoni A. et al. Safety of components and platforms of COVID-19 vaccines considered for use in pregnancy: A rapid review. Vaccine 2021; 39: 5891-5908
  • 24 Fu W, Sivajohan B, McClymont E. et al. Systematic review of the safety, immunogenicity, and effectiveness of COVID-19 vaccines in pregnant and lactating individuals and their infants. Int J Gynaecol Obstet 2021; 156: 406-417
  • 25 Burwick RM, Yawetz S, Stephenson KE. et al. Compassionate Use of Remdesivir in Pregnant Women with Severe Covid-19. Clin Infect Dis 2020; 73: e3996-e4004
  • 26 Jorgensen SCJ, Davis MR, Lapinsky SE. A review of remdesivir for COVID-19 in pregnancy and lactation. J Antimicrob Chemother 2021; 77: 24-30
  • 27 Rochwerg B, Agarwal A, Siemieniuk RA. et al. A living WHO guideline on drugs for covid-19. Bmj 2020; 370: m3379
  • 28 Saad AF, Chappell L, Saade GR, Pacheco LD. Corticosteroids in the Management of Pregnant Patients With Coronavirus Disease (COVID-19). Obstet Gynecol 2020; 136: 823-826
  • 29 Wong AY, MacKenna B, Morton CE. et al. Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19: an OpenSAFELY cohort analysis based on two cohorts. Ann Rheum Dis 2021; 80: 943-951
  • 30 Walker KF, O’Donoghue K, Grace N. et al. Maternal transmission of SARS-COV-2 to the neonate, and possible routes for such transmission: a systematic review and critical analysis. Bjog 2020; 127: 1324-1336
  • 31 Cai J, Tang M, Gao Y. et al. Cesarean Section or Vaginal Delivery to Prevent Possible Vertical Transmission From a Pregnant Mother Confirmed With COVID-19 to a Neonate: A Systematic Review. Front Med (Lausanne) 2021; 8: 634949